Michele Mencer

About Michele Mencer

Senior life sciences executive with 25+ years of experience building and scaling specialty franchises, leading large-scale commercial transformations and delivering durable portfolio value. My career has been defined by navigating high-stakes inflections, from orchestrating multi-billion dollar M&A integrations to building new franchises from inception and reversing declines for flagship global brands. I bring enterprise-level commercial leadership with full P&L accountability for multi-brand portfolios in highly complex and competitive markets across launch, growth, and lifecycle management. My leadership is anchored by proven Boardroom presence with a track record of leading fiscal governance, policy strategy, and multi-layered stakeholder management, skills I apply both to multi-billion dollar portfolios and public-sector oversight.I am a strategic architect for high-performing, cross-functional teams during critical junctures across new franchises, whitespace markets, turnarounds, and enterprise transformations. I consistently deliver outcomes at scale, on time, and often ahead of plan by tightly integrating strategy, execution, talent development and organizational capability building.My background spans pharmaceutical, medical device, health insurance and government, with U.S. and global leadership across commercial portfolio strategy, enterprise transformation, launch excellence, franchise leadership, marketing, market access, HEOR and business development. Therapeutic experience includes rare and ultra-rare renal disease, classical hematology (paroxysmal nocturnal hemoglobinuria), cardiovascular (pulmonary arterial hypertension, atherosclerosis, heart failure, thrombosis), neuroscience (multiple sclerosis, migraine), women\'s health, pain, regenerative medicine, breast cancer and reconstructive surgery, general surgery and aesthetics.

Experience

1. Vice President and General Manager, Us Renal Portfolio and Non-malignant Classical Hematology

   Novartis

   Dec 2023 — Present · New York, NY, US

   Recognized by Executive Leadership for delivering top-tier enterprise impact; Enterprise leader accountable for building Novartis\' renal franchise from inception to category leadership, with full P&L ownership post $3B acquisition and mandate to scale rare disease capabilities. Secured enterprise capital for clinical acceleration; accountable for complex hematologic disease, Paroxysmal Nocturnal Hemoglobinuria (PNH) commercialization; cross-functional, global leadership; and long-term portfolio value creation.

Education

• Penn State University

  Bachelor of Science - BS, Health Policy Administration

• Rutgers University

  Master of Public Health - MPH

• Rutgers Business School

  Master of Business Administration - MBA, Finance

Skills

• Leadership
• Business Development
• Product Launch
• Product Marketing
• Market Research
• Business Strategy
• Oncology
• Team Building
• Management
• Strategic Planning
• Pharmaceutical Sales
• Business Intelligence
• Cross-Functional Team Leadership
• Competitive Intelligence
• Marketing Strategy
• Biotechnology
• Forecasting
• Micro Writing
• Medical Devices
• Commercialization
• Strategy
• Global Marketing
• Pharmaceutical Industry
• Market Analysis
• Competitive Analysis